Evaluation of Demographic and Clinical Characteristics of Turkish Patients With Primary Cutaneous Melanoma: A 5-Year Experience of a Tertiary Referral Center.

IF 2.5 4区 医学 Q2 DERMATOLOGY Dermatology practical & conceptual Pub Date : 2024-07-01 DOI:10.5826/dpc.1403a135
Irfan Gahramanov, Gulsen Akoglu, Eda Karaismailoglu, Nuri Karadurmus
{"title":"Evaluation of Demographic and Clinical Characteristics of Turkish Patients With Primary Cutaneous Melanoma: A 5-Year Experience of a Tertiary Referral Center.","authors":"Irfan Gahramanov, Gulsen Akoglu, Eda Karaismailoglu, Nuri Karadurmus","doi":"10.5826/dpc.1403a135","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Data about the demographic and clinical characteristics of melanoma patients in Turkey is limited.</p><p><strong>Objectives: </strong>Data about the demographic and clinical characteristics of melanoma patients in Turkey is limited. We aimed to review the features of patients with primary cutaneous melanoma (PCM) diagnosed and treated in a tertiary referral center.</p><p><strong>Methods: </strong>The medical records of melanoma patients followed up by the Departments of Dermatology and Medical Oncology were retrospectively reviewed.</p><p><strong>Results: </strong>Within a 5-year period, 180 patients had been diagnosed with melanoma. Of all, 158 (87.8%) had PCM, 9 (5%) had mucosal melanoma, 9 (5%) had unknown primary melanoma, and 4 (2.2%) had ocular melanoma. Of 146 patients with PCM, 32.9% had stage I, 28.8% had stage II, 17.8% had stage III, and 20.5% had stage IV disease. The most common subtype was superficial spreading melanoma (38.8%). A statistically significant correlation was found between the patients Breslow thickness and lymph node involvement, histopathological subtype, and tumor ulceration (P < 0.001). Among all PCM patients, those in stage IV had the lowest 5-year survival rate when compared to the other disease stages (P < 0.001).</p><p><strong>Conclusions: </strong>Relatively younger age at melanoma diagnosis, frequent presence of thick (> 4 mm) tumor, and frequent acral lentiginous subtype are the most remarkable features that suggest the low awareness and knowledge of melanoma in our population.</p>","PeriodicalId":11168,"journal":{"name":"Dermatology practical & conceptual","volume":"14 3","pages":""},"PeriodicalIF":2.5000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11314554/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Dermatology practical & conceptual","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.5826/dpc.1403a135","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"DERMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Data about the demographic and clinical characteristics of melanoma patients in Turkey is limited.

Objectives: Data about the demographic and clinical characteristics of melanoma patients in Turkey is limited. We aimed to review the features of patients with primary cutaneous melanoma (PCM) diagnosed and treated in a tertiary referral center.

Methods: The medical records of melanoma patients followed up by the Departments of Dermatology and Medical Oncology were retrospectively reviewed.

Results: Within a 5-year period, 180 patients had been diagnosed with melanoma. Of all, 158 (87.8%) had PCM, 9 (5%) had mucosal melanoma, 9 (5%) had unknown primary melanoma, and 4 (2.2%) had ocular melanoma. Of 146 patients with PCM, 32.9% had stage I, 28.8% had stage II, 17.8% had stage III, and 20.5% had stage IV disease. The most common subtype was superficial spreading melanoma (38.8%). A statistically significant correlation was found between the patients Breslow thickness and lymph node involvement, histopathological subtype, and tumor ulceration (P < 0.001). Among all PCM patients, those in stage IV had the lowest 5-year survival rate when compared to the other disease stages (P < 0.001).

Conclusions: Relatively younger age at melanoma diagnosis, frequent presence of thick (> 4 mm) tumor, and frequent acral lentiginous subtype are the most remarkable features that suggest the low awareness and knowledge of melanoma in our population.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
评估土耳其原发性皮肤黑色素瘤患者的人口统计学和临床特征:一家三级转诊中心的五年经验。
简介有关土耳其黑色素瘤患者的人口和临床特征的数据十分有限:有关土耳其黑色素瘤患者的人口统计学和临床特征的数据十分有限。我们旨在回顾在一家三级转诊中心诊断和治疗的原发性皮肤黑色素瘤(PCM)患者的特征:方法:回顾性审查皮肤科和肿瘤内科随访的黑色素瘤患者的病历:结果:5 年内共有 180 名患者被确诊为黑色素瘤。其中,158 人(87.8%)罹患 PCM,9 人(5%)罹患粘膜黑色素瘤,9 人(5%)罹患原发性不明黑色素瘤,4 人(2.2%)罹患眼部黑色素瘤。在 146 名 PCM 患者中,32.9% 属于 I 期,28.8% 属于 II 期,17.8% 属于 III 期,20.5% 属于 IV 期。最常见的亚型是浅表扩散型黑色素瘤(38.8%)。患者的布瑞斯洛厚度与淋巴结受累、组织病理学亚型和肿瘤溃疡之间存在统计学意义上的明显相关性(P < 0.001)。在所有 PCM 患者中,与其他疾病分期相比,IV 期患者的 5 年生存率最低(P < 0.001):结论:黑色素瘤确诊年龄相对较小、肿瘤较厚(> 4 毫米)且多为尖状色素亚型是最显著的特征,这表明我国人群对黑色素瘤的认知度和知识水平较低。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
1.40
自引率
0.00%
发文量
217
期刊最新文献
Impact of Pemphigus on Sleep Quality: A Prospective Observational Single-Center Case-Control Study. Review - Expert Opinion on Antibiotics and Antibiotic Resistance in Dermatology. A prospective Real-Life Multicenter Study of Tildrakizumab 200 mg in Patients with Moderate-Severe Psoriasis: Who is the Ideal Patient? Optimized Calcium Hydroxylapatite Formulation and Its Injection Technique for Hand Rejuvenation: A Retrospective Study. Epidemiology and Risk Factors of Actinic Keratosis. What is New for The Management for Sun-Damaged Skin.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1